<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00423241</url>
  </required_header>
  <id_info>
    <org_study_id>200-06-004</org_study_id>
    <nct_id>NCT00423241</nct_id>
  </id_info>
  <brief_title>SEMPERFLO* Pain Management System in Inguinal Hernia Repair</brief_title>
  <official_title>A Prospective, Randomized, Exploratory Comparison of the SEMPERFLO* Pain Management System to a Commercially Available Pain Relief System in Subjects Undergoing Open Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the clinical performance of the SEMPERFLO* Pain Management System
      with another commercial pain relief system using 0.5% bupivacaine following unilateral, open,
      inguinal hernia repair procedures.

      *Trademark
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain will be evaluated up to 5 days after surgery Subjects will be followed for 30 days after
      surgery.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Market dynamics including other technologies made the project not viable.
  </why_stopped>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dynamic pain (pain measured with coughing) measured using a ten-point visual analog scale</measure>
    <time_frame>twenty-four hours post procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Narcotic and non-narcotic analgesic usage</measure>
    <time_frame>24, 48, 72, 96 and 120 hours post- procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric pain scale scores at rest and with coughing</measure>
    <time_frame>24, 48, 72, 96, and 120 hours post-procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>SEMPERFLO Pain Management System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ON-Q PainBuster Post-Op Pain Relief System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SEMPERFLO Pain Management System</intervention_name>
    <description>continuous infusion of 0.5% bupivacaine at 2mL per hour</description>
    <arm_group_label>SEMPERFLO Pain Management System</arm_group_label>
    <other_name>Pain management system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ON-Q PainBuster Post-Op Pain Relief System</intervention_name>
    <description>continuous infusion of 0.5% bupivacaine at 2mL per hour</description>
    <arm_group_label>ON-Q PainBuster Post-Op Pain Relief System</arm_group_label>
    <other_name>Pain management system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is a candidate for primary, non-emergent unilateral, open inguinal hernia
             repair procedure

          -  Subject is 18 years or older

          -  Subject must be willing to participate in the study, and provide informed consent to
             participate.

        Exclusion Criteria:

          -  Subjects undergoing recurrent hernia repair;

          -  Subjects who plan to undergo another elective surgical procedure prior to the
             completion of this study;

          -  Subjects with known allergy to bupivacaine;

          -  Subjects with immunodeficiency diseases (including known HIV);

          -  Subjects with any findings identified by the surgeon that may preclude conduct of the
             study;

          -  Subjects who are known current alcohol and/or drug abusers;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Weisberg, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boca Raton Community Hospital</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jacksonville Center for Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universtiy of Tennessee</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Texas Surgery Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michale E. DeBakey VA Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2007</study_first_submitted>
  <study_first_submitted_qc>January 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2007</study_first_posted>
  <last_update_submitted>August 20, 2010</last_update_submitted>
  <last_update_submitted_qc>August 20, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jonathan Batiller, MBA</name_title>
    <organization>Ethicon Inc.</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

